Korro Bio KRRO
NASDAQ KRRO
$9.58 -0.33 (-3.33%)
As of: Oct 1, 2026 · 12:18 PM EDT

Korro Bio (KRRO) Other financing activities (2018 - 2023)

Updated

Korro Bio (KRRO) reported Other financing activities of $2.63 million for Q4 2023.

Analysis

Korro Bio (KRRO) Other financing activities (2018 - 2023) Analysis & Trends

For FY2023, Korro Bio posted Other financing activities of -$2,000.

  • By year, Other financing activities came in at -$44,000 in FY2022.
  • Per Business Quant data, the three quarters before Q4 2023 came in at -$2.41 million (Q3 2023), -$76,000 (Q2 2023) and -$150,000 (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Korro Bio 145.73 Mn -250.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 2.63 Mn
Sep 30, 2023 -2.41 Mn
Jun 30, 2023 -76,000.00
Mar 31, 2023 -150,000.00
Dec 31, 2018 2.00 Mn
API Access

Korro Bio Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=KRRO&period=max&api_key=YOUR_API_KEY